Badrul A. Chowdhury - 15 May 2021 Form 4 Insider Report for Savara Inc (SVRA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Lowrance as attorney-in-fact for Badrul Chowdhury
Issuer symbol
SVRA
Transactions as of
15 May 2021
Net transactions value
-$77,870
Form type
4
Filing time
17 May 2021, 21:57:01 UTC
Next filing
09 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SVRA Common Stock Options Exercise $0 +200,000 $0.000000 200,000 15 May 2021 Direct
transaction SVRA Common Stock Sale $77,870 -50,000 -25% $1.56 150,000 17 May 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SVRA Restricted Stock Units Options Exercise $0 -200,000 -100% $0.000000* 0 15 May 2021 Common Stock 200,000 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2020 in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 15, 2021.
F2 The price is a weighted average sale price. The sale prices ranged from $1.50 to $1.61. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The restricted stock units vested in full on May 15, 2021.